LITS
Lite Strategy, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$41.55M
P/E Ratio
—
EPS
$-1.82
Beta
0.10
52W High
$8.25
52W Low
$0.95
50-Day MA
$1.15
200-Day MA
$2.41
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
4.62
PEG Ratio
2.22
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-2.11M |
| EBITDA | $-16.13M |
| Operating Margin | 0.00% |
| Return on Equity | -76.40% |
| Return on Assets | -19.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.23 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 0.30 |
| EV/Revenue | 0.812 |
| EV/EBITDA | 2.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $36.36M |
| Float | $30.51M |
| % Insiders | 11.20% |
| % Institutions | 22.75% |
Data last updated: 4/8/2026